Literature DB >> 7399665

Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.

I Ohishi, G Sakaguchi.   

Abstract

Clostridium botulinum type C progenitor toxins of different molecule sizes, C-L (16S) and C-M (12S), were purified from cultures of strains 573, Stockholm, and CB-19. C-L toxin showed some hemaggglutinin activity, whereas C-M toxin did not. Neither C-L nor C-M toxin was activated upon trypsinization. Molecular dissociation of purified type C-L and C-M toxins into toxic and nontoxic components was demonstrated by sucrose density gradient ultracentrifugation and diethylaminoethyl-Sephadex chromatography at pH 8.0. The molecular construction of type C progenitor toxin appears to be analogous to that reported for botulinum toxins of other types. C-L and D-L toxins showed higher oral toxicities to mice than did C-M or D-M toxin. Such higher oral toxicities were ascribed to the higher stabilities of these toxins in gastric and intestinal juices.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399665      PMCID: PMC550933          DOI: 10.1128/iai.28.2.303-309.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Studies on mink food experimentally inoculated with toxin-free spores of Clostridium botulinum types A,B,C, and E.

Authors:  R O WAGENAAR; G M DACK; D P MAYER
Journal:  Am J Vet Res       Date:  1953-07       Impact factor: 1.156

2.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

3.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

4.  Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.

Authors:  I Ohishi; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1977-08

5.  Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.

Authors:  M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

6.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

7.  Conversion of toxigenicity in Clostridium botulinum type C.

Authors:  K Inoue; H Iida
Journal:  Jpn J Microbiol       Date:  1970-01

8.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

9.  Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice.

Authors:  G Sakaguchi; S Sakaguchi; H Kondo
Journal:  Jpn J Med Sci Biol       Date:  1968-12

10.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more
  25 in total

1.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

2.  Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.

Authors:  Karine Bagramyan; Bruce E Kaplan; Luisa W Cheng; Jasmin Strotmeier; Andreas Rummel; Markus Kalkum
Journal:  Anal Chem       Date:  2013-05-22       Impact factor: 6.986

3.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

5.  Random phage display-based screening of peptides that bind to botulinum neurotoxin binding protein, nontoxic nonhemagglutinin.

Authors:  Yoshimasa Sagane; Keita Miyata; Sayuri Kurihara; Tohru Yoneyama; Ken Inui; Shin-Ichiro Miyashita; Shintaro Hayashi; Tomonori Suzuki; Koichi Niwa; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2013-03-16       Impact factor: 2.188

Review 6.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

7.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

Review 8.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

9.  Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).

Authors:  M Matsuda; K Ozutsumi; P Y Du; N Sugimoto
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

10.  Oral toxicities of Clostridium botulinum type A and B toxins from different strains.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.